tradmap

PRPO Precipio, Inc.

$26.08 -5.37%

Updated

Healthcare · Laboratory Analytical Instruments

Precipio, Inc. (PRPO) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $47 million. Shares last traded at $26.08, 22.5% below their 52-week high. Over the past year the stock is up 83.3%. Net profit margin is -1.3%, above the peer median of -1.7%. Revenue grew 30.5% year over year.

Market Cap
$47M
Shares Out
1.8M
EPS (TTM)
$-2.85
P/E Ratio
P/S Ratio
1.69
P/B Ratio
3.16
Dividend / Share
Dividend Yield
52-Week High
$33.63
52-Week Low
$13.81
Volume
51,033
Avg Vol (3m)
6,082.492

Performance

1W
-11.02%
1M
+15.68%
3M
+11.17%
6M
+0.37%
YTD
+15.65%
1Y
+83.27%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
48.60
SMA (50)
$24.77
SMA (200)
$24.90
Price vs SMA50
+5.30%
Price vs SMA200
+4.72%
ATR (14)
$2.09

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$28M
Net Income
$-0M
Gross Margin
43.3%
Operating Margin
-5.6%
Net Margin
-1.3%
Return on Equity
-2.5%
Return on Assets
-1.7%
Current Ratio
1.77
Debt / Equity
0.02
Revenue Growth (YoY)
+30.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-0.93 2026-08-14
Q1 2026 $-0.81 2026-05-14
FY 2025 $-0.23 2026-03-30
Q3 2025 $-0.57 2025-11-14
Q2 2026 $-0.54 2026-08-14
Q1 2026 $-0.59 2026-05-14

Full earnings history →

Laboratory Analytical Instruments peers

PRPO vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/S vs peers
1.69 / 5.01 med
-66% discount
Net margin vs peers
-1.3% / -1.7% med
above median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.